(Q46627323)

English

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders

scientific article published on 12 March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia-reperfusion injury in mice with metabolic disorders (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

reperfusion injury

1 reference

based on heuristic

inferred from title

Kenichi Tsujita

3

object named as

Kenichi Tsujita

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

2

object named as

Koichi Kaikita

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

9

object named as

Hisao Ogawa

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

7

object named as

Seigo Sugiyama

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

Masakazu Matsukawa

5

object named as

Masakazu Matsukawa

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

Shunichiro Fuchigami

6

object named as

Shunichiro Fuchigami

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

1

object named as

Tsuyoshi Honda

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

Takanori Hayasaki

4

object named as

Takanori Hayasaki

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

Motohiro Takeya

10

object named as

Motohiro Takeya

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

author name string

Naomi Sakashita

8

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

publication date

12 March 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

44

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

915-926

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

Pathophysiology and molecular mechanisms of visceral fat syndrome: the Japanese experience

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Obesity and Cardiovascular Disease: Pathophysiology, Evaluation, and Effect of Weight Loss

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Magnitude of sustained multiple risk factors for ischemic heart disease in Japanese employees: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Myocardial infarction and heart failure in the db/db diabetic mouse

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Genetic analysis of non-insulin-dependent diabetes mellitus in KK and KK-Ay mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

BM 17.0744: a structurally new antidiabetic compound with insulin-sensitizing and lipid-lowering activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates myocardial ischemia/reperfusion injury in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Rosiglitazone treatment in Zucker diabetic Fatty rats is associated with ameliorated cardiac insulin resistance and protection from ischemia/reperfusion-induced myocardial injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Increased oxidative stress in obesity and its impact on metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Angiotensin II type-1 receptor blocker valsartan enhances insulin sensitivity in skeletal muscles of diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Visceral fat is a major contributor for multiple risk factor clustering in Japanese men with impaired glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

CC chemokine receptor-2 deficiency attenuates oxidative stress and infarct size caused by myocardial ischemia-reperfusion in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Targeted deletion of class A macrophage scavenger receptor increases the risk of cardiac rupture after experimental myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

The role of neutrophils in myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

TLR4 links innate immunity and fatty acid-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Obesity induces a phenotypic switch in adipose tissue macrophage polarization

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Obesity-induced inflammatory changes in adipose tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Inflammation and metabolic disorders

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

The inflammatory response in myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Inflammatory cytokines and postmyocardial infarction remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Rosiglitazone, a ligand of the peroxisome proliferator-activated receptor-gamma, reduces acute inflammation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Diabetic state-induced modification of Ca, Mg, Fe and Zn content of skeletal, cardiac and smooth muscles

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Low serum magnesium levels and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Geographic variation in the incidence of myocardial calcification associated with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2008.03.004

7 January 2021

Identifiers

10.1016/J.YJMCC.2008.03.004

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18436235

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46627323&oldid=2123047554"